Stay updated on DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab
Sign up to get notified when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.

Latest updates to the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page
- ChecktodayChange DetectedThe footer revision label changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, with no apparent changes to the study record.SummaryDifference0.1%

- Check28 days agoChange DetectedA banner announces NIH website updates and explains that the term “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.SummaryDifference0.8%

- Check35 days agoChange DetectedThe ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check42 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check63 days agoChange DetectedThe Record History now includes a new revision entry, v3.7.0, replacing the previous revision v3.6.6. This change represents an update to the page's version history rather than modifications to trial data or content.SummaryDifference0.1%

Stay in the know with updates to DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab
Enter your email address, and we'll notify you when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.